Elevated plasma eotaxin levels in patients with acute asthma
Elevated plasma eotaxin levels in patients with acute asthma
复制标题
DOI:
10.1016/s0091-6749(99)70288-5
复制
发表时间:
1999-10-01
影响因子:
14.2
通讯作者:
Hanrahan, JP
中科院分区:
文献类型:
--
作者:
Lilly, CM;Woodruff, PG;Hanrahan, JP
Background: The eosinophil chemotactic and activating effects of eotaxin and the known association of eosinophils with asthma suggest that eotaxin expression is increased during asthma exacerbations.Objective: We sought to determine whether plasma eotaxin levels are elevated in patients presenting for emergency treatment of acute asthma and to correlate eotaxin levels with disease activity and responses to treatment.Methods: A case-control study of plasma eotaxin levels was performed in the 36 patients who presented for emergency asthma treatment and 133 age-, sex-, and ethnicity-matched subjects with stable asthma,Results: Plasma eotaxin levels were significantly higher in 36 patients with acute asthma symptoms and airflow obstruction (520 pg/mL [250, 1100 pg/mL]; geometric mean [-1 SD, +1 SD]) than in 133 subjects with stable asthma (350 pg/mL [190, 620 pg/ml]; P = .0008), Among the patients with emergency asthma flares, those who responded to asthma treatment with an increase in peak expiratory flow rate by an amount equal to at least 20% of their predicted normal value had lower eotaxin levels than those who did not (410 pg/mL [210, 800 pg/mL] and 660 pg/mL [300, 1480 pg/mL], respectively; P = .01).Conclusion: These findings imply that eotaxin either is mechanistically involved in acute asthma or series as a biomarker for activity of the CCR3 receptor ligand system, which is functionally linked to asthma.